BACKGROUND: The general anesthetics, isoflurane and sevoflurane, cause developmental abnormalities in neonatal animal models via incompletely understood mechanisms. Despite many common molecular targets, isoflurane and sevoflurane exhibit substantial differences in their actions. The authors sought to determine whether these differences can also be detected at the level of neurodevelopmental effects. METHODS: Postnatal rats, 4-6 days old, were exposed to 1.2% isoflurane or 2.1% sevoflurane for 1-6 h and studied for immediate and delayed effects. RESULTS: Isoflurane exposure was associated with weaker seizure-like electroencephalogram patterns than sevoflurane exposure. Confronted with a new environment at a juvenile age, the sevoflurane-exposed rats spent significantly more time in an "immobile" state than unexposed rats. Electroencephalographic (mean ± SE, 55.5 ± 12.80 s vs. 14.86 ± 7.03 s; P = 0.014; n = 6-7) and spontaneous behavior (F(2,39) = 4.43; P = 0.018) effects of sevoflurane were significantly diminished by pretreatment with the Na-K-2Cl cotransporter inhibitor bumetanide, whereas those of isoflurane were not. Pretreatment with bumetanide, however, diminished isoflurane-induced activation of caspase-3 in the cerebral cortex (F(2,8) = 22.869; P = 0.002) and prevented impairment in sensorimotor gating function (F(2,36) = 5.978; P = 0.006). CONCLUSIONS: These findings in combination with results previously reported by the authors suggest that isoflurane and sevoflurane produce developmental effects acting via similar mechanisms that involve an anesthetic-induced increase in neuronal activity. At the same time, differences in their effects suggest differences in the mediating mechanisms and in their relative safety profile for neonatal anesthesia.
BACKGROUND: The general anesthetics, isoflurane and sevoflurane, cause developmental abnormalities in neonatal animal models via incompletely understood mechanisms. Despite many common molecular targets, isoflurane and sevoflurane exhibit substantial differences in their actions. The authors sought to determine whether these differences can also be detected at the level of neurodevelopmental effects. METHODS: Postnatal rats, 4-6 days old, were exposed to 1.2% isoflurane or 2.1% sevoflurane for 1-6 h and studied for immediate and delayed effects. RESULTS:Isoflurane exposure was associated with weaker seizure-like electroencephalogram patterns than sevoflurane exposure. Confronted with a new environment at a juvenile age, the sevoflurane-exposed rats spent significantly more time in an "immobile" state than unexposed rats. Electroencephalographic (mean ± SE, 55.5 ± 12.80 s vs. 14.86 ± 7.03 s; P = 0.014; n = 6-7) and spontaneous behavior (F(2,39) = 4.43; P = 0.018) effects of sevoflurane were significantly diminished by pretreatment with the Na-K-2Cl cotransporter inhibitor bumetanide, whereas those of isoflurane were not. Pretreatment with bumetanide, however, diminished isoflurane-induced activation of caspase-3 in the cerebral cortex (F(2,8) = 22.869; P = 0.002) and prevented impairment in sensorimotor gating function (F(2,36) = 5.978; P = 0.006). CONCLUSIONS: These findings in combination with results previously reported by the authors suggest that isoflurane and sevoflurane produce developmental effects acting via similar mechanisms that involve an anesthetic-induced increase in neuronal activity. At the same time, differences in their effects suggest differences in the mediating mechanisms and in their relative safety profile for neonatal anesthesia.
Authors: Andrew M White; Philip A Williams; Damien J Ferraro; Suzanne Clark; Shilpa D Kadam; F Edward Dudek; Kevin J Staley Journal: J Neurosci Methods Date: 2005-12-05 Impact factor: 2.390
Authors: Astrid G Stucke; Edward J Zuperku; Viseslav Tonkovic-Capin; Mirko Krolo; Francis A Hopp; John P Kampine; Eckehard A E Stuth Journal: Anesthesiology Date: 2005-07 Impact factor: 7.892
Authors: Vesna Jevtovic-Todorovic; Richard E Hartman; Yukitoshi Izumi; Nicholas D Benshoff; Krikor Dikranian; Charles F Zorumski; John W Olney; David F Wozniak Journal: J Neurosci Date: 2003-02-01 Impact factor: 6.167
Authors: Robert Dickinson; Brian K Peterson; Paul Banks; Constantinos Simillis; Juan Carlos Sacristan Martin; Carlos A Valenzuela; Mervyn Maze; Nicholas P Franks Journal: Anesthesiology Date: 2007-11 Impact factor: 7.892
Authors: Wengang Cao; Christopher Pavlinec; Nikolaus Gravenstein; Christoph N Seubert; Anatoly E Martynyuk Journal: Anesthesiology Date: 2012-10 Impact factor: 7.892
Authors: Justine D Landin; Magdalena Palac; Jenna M Carter; Yvette Dzumaga; Jessica L Santerre-Anderson; Gina M Fernandez; Lisa M Savage; Elena I Varlinskaya; Linda P Spear; Scott D Moore; H Scott Swartzwelder; Rebekah L Fleming; David F Werner Journal: Neuropharmacology Date: 2019-03-26 Impact factor: 5.250
Authors: Michael R DiGruccio; Srdjan Joksimovic; Pavle M Joksovic; Nadia Lunardi; Reza Salajegheh; Vesna Jevtovic-Todorovic; Mark P Beenhakker; Howard P Goodkin; Slobodan M Todorovic Journal: J Neurosci Date: 2015-01-28 Impact factor: 6.167